Beetz, R; Bachmann, HJ; Gatermann, S et al.
Harnwegsinfektionen im Säuglings- und Kinderalter. Consensus-Empfehlungen zu Diagnostik, Therapie und Prophylaxe.Monatsschr Kinderheilkd. Bd. 155. 2007 S. 261-271
Beetz, R; Bachmann, HJ; Gatermann, S et al.
Harnwegsinfektionen im Säuglings- und Kindesalter. Consensusempfehlungen zu Diagnostik, Therapie und ProphylaxeUrologe. Bd. 46. H. 2. 2007 S. 112-123
Limberger, A; Beck, M; Delgado-Sanchez, S et al.
Hearing loss in patients with Fabry diseaseHNO. Bd. 55. 2007 S. 185-189
Schmitt, HJ; Booy, R; Aston, R et al.
How to optimise the coverage rate of infant and adult immunisations in Europe.BMC Med. Bd. 5. 2007 S. 11
Mannhardt-Laakmann, W
Hypertonie im KindesalterTh Lenz (Hrsg). Hypertonie in Klinik und Praxis. Stuttgart, New York: Schattauer 2007
Knuf, M; Faber, J; Huth, RG et al.
Identification of a novel compound heterozygote SCO2 mutation in cytochrome c oxidase deficient fatal infantile cardioencephalomyopathyActa Paediatr Suppl. Bd. 96. H. 1. 2007 S. 130-132
Zepp, F; Behre, U; Kindler, K et al.
Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months.Eur J Pediatr. Bd. 166. H. 8. 2007 S. 857-64
Zepp, F; Habermehl, P; Knuf, M et al.
Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.Vaccine. Bd. 25. H. 29. 2007 S. 5248-52
Schmitt, HJ; Maechler, G; Habermehl, P et al.
Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine.Clin Vaccine Immunol. Bd. 14. H. 4. 2007 S. 426-34
Zepp, F; Behre, U; Kindler, K et al.
Immunolgenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphteria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 monthsEur J Pediatr. Bd. 166. H. 8. 2007 S. 857-64